Agarwal G, Gabrani R (2020) Antiviral peptides: identification and validation. Int J Pept Res Ther
Agarwal G, Gabrani R (2021) Antiviral peptides: identification and validation. Int J Pept Res Ther 27:149–168
Al Musaimi O, Al Shaer D, Albericio F, de la Torre BG (2023) 2022 FDA TIDES (Peptides and Oligonucleotides) Harvest. Pharmaceuticals (Basel), 16
Al Shaer D, Al Musaimi O, Albericio F, de la Torre BG (2024) 2023 FDA TIDES (peptides and oligonucleotides) Harvest. Pharmaceuticals (Basel), 17
Auvynet C, Rosenstein Y (2009) Multifunctional host defense peptides: antimicrobial peptides, the small yet big players in innate and adaptive immunity. FEBS J 276:6497–6508
Badani H, Garry RF, Wimley WC (2014) Peptide entry inhibitors of enveloped viruses: the importance of interfacial hydrophobicity. Biochim Biophys Acta 1838:2180–2197
Article PubMed PubMed Central Google Scholar
Balmeh N, Mahmoudi S, Fard NA (2021) Manipulated bio antimicrobial peptides from probiotic bacteria as proposed drugs for COVID-19 disease. Inf Med Unlocked 23:100515
Boniotti MB, Papetti A, Lavazza A, Alborali G, Sozzi E, Chiapponi C, Faccini S, Bonilauri P, Cordioli P, Marthaler D (2016) Porcine epidemic Diarrhea Virus and Discovery of a recombinant swine enteric coronavirus, Italy. Emerg Infect Dis 22:83–87
Article PubMed PubMed Central Google Scholar
Bulet P, Stöcklin R, Menin L (2004) Anti-microbial peptides: from invertebrates to vertebrates. Immunol Rev 198:169–184
Cao L, Ge X, Gao Y, Zarlenga DS, Wang K, Li X, Qin Z, Yin X, Liu J, Ren X, Li G (2015) Putative phage-display epitopes of the porcine epidemic diarrhea virus S1 protein and their anti-viral activity. Virus Genes 51:217–224
Article PubMed PubMed Central Google Scholar
Charoenkwan P, Anuwongcharoen N, Nantasenamat C, Hasan MM, Shoombuatong W (2021) In Silico Approaches for the prediction and analysis of antiviral peptides: a review. Curr Pharm Des 27:2180–2188
Chen CH, Lu TK (2020) Development and challenges of antimicrobial peptides for therapeutic applications. Antibiot (Basel), 9
Cheng VC, Lau SK, Woo PC, Yuen KY (2007) Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clin Microbiol Rev 20:660–694
Article PubMed PubMed Central Google Scholar
Crouch CF, Daly J, Henley W, Hannant D, Wilkins J, Francis MJ (2005) The use of a systemic prime/mucosal boost strategy with an equine influenza ISCOM vaccine to induce protective immunity in horses. Vet Immunol Immunopathol 108:345–355
Dai C, Ma Y, Zhao Z, Zhao R, Wang Q, Wu Y, Cao Z, Li W (2008) Mucroporin, the first cationic host defense peptide from the venom of Lychas Mucronatus. Antimicrob Agents Chemother 52:3967–3972
Article PubMed PubMed Central Google Scholar
Dennis H Maria, Jenckel, Anja, Petrov, Mathias, Ritzmann, Julia,Stadler (2015). Comparison of porcine epidemic diarrhea viruses from Germany and the United States, 2014. Emerging infectious diseases
Dhingra N, Bhardwaj R, Bhardwaj U, Kapoor K (2023) Design of hACE2-based small peptide inhibitors against spike protein of SARS-CoV-2: a computational approach. Struct Chem, 1–14
Dias Rde O, Franco OL (2015) Cysteine-stabilized αβ defensins: from a common Fold to antibacterial activity. Peptides 72:64–72
Ding J, Chou Y, Y,Chang TL (2009) Defensins in viral infections. J Innate Immun 1:413–420
Fabrizio A, Grisafi A, Meyer B, Ceriotti M, Corminboeuf C (2019) Electron density learning of non-covalent systems. Chem Sci 10:9424–9432
Article PubMed PubMed Central Google Scholar
Fauci AS, Morens DM (2012) The perpetual challenge of infectious diseases. N Engl J Med 366:454–461
Findlay F, Proudfoot L, Stevens C, Barlow PG (2016) Cationic host defense peptides; novel antimicrobial therapeutics against category A pathogens and emerging infections. Pathog Glob Health 110:137–147
Article PubMed PubMed Central Google Scholar
Furqan M (2023) Trofinetide-a new chapter in rett syndrome’s treatment. Front Pharmacol 14:1284035
Article PubMed PubMed Central Google Scholar
Ganz T (2003) Defensins: antimicrobial peptides of innate immunity. Nat Rev Immunol 3:710–720
Gentilucci L, De Marco R, Cerisoli L (2010) Chemical modifications designed to improve peptide stability: incorporation of non-natural amino acids, pseudo-peptide bonds, and cyclization. Curr Pharm Des 16:3185–3203
Gontsarik M, Yaghmur A, Ren Q, Maniura-Weber K, Salentinig S (2019) From structure to function: pH-Switchable Antimicrobial Nano-Self-assemblies. ACS Appl Mater Interfaces 11:2821–2829
Graham BS, Sullivan NJ (2018) Emerging viral diseases from a vaccinology perspective: preparing for the next pandemic. Nat Immunol 19:20–28
Gu JP, Yue XW, Xing R, Li CY, Yang ZB (2012) Progress in genetically engineered vaccines for porcine transmissible gastroenteritis virus. Revue De Médecine Vétérinaire 163:107–111
Guo N, Zhang B, Hu H, Ye S, Chen F, Li Z, Chen P, Wang C, He Q (2018) Caerin1.1 suppresses the growth of Porcine Epidemic Diarrhea Virus in Vitro via Direct binding to the Virus. Viruses, 10
Gwyer Findlay E, Currie SM, Davidson DJ (2013) Cationic host defence peptides: potential as antiviral therapeutics. BioDrugs 27:479–493
Article PubMed PubMed Central Google Scholar
Han L, Liu P, Zhang H, Li F, Liu A (2017) Phage capsid protein-directed MnO(2) nanosheets with peroxidase-like activity for spectrometric biosensing and evaluation of antioxidant behaviour. Chem Commun (Camb) 53:5216–5219
Han L, Xia H, Yin L, Petrenko VA, Liu A (2018) Selected landscape phage probe as selective recognition interface for sensitive total prostate-specific antigen immunosensor. Biosens Bioelectron 106:1–6
He Y, Yang L, Yuan JJ, Zhu HH, Shao LY (2020) [Effect of ultrasound contrast agent targeting gelatin on uptake of mouse ascites hepatocellular carcinoma cell lines with high lymphatic metastasis]. Zhonghua Zhong Liu Za Zhi 42:319–324
Hernández PP, Mahlakoiv T, Yang I, Schwierzeck V, Nguyen N, Guendel F, Gronke K, Ryffel B, Hoelscher C, Dumoutier L, Renauld JC, Suerbaum S, Staeheli P, Diefenbach A (2015) Interferon-λ and interleukin 22 act synergistically for the induction of interferon-stimulated genes and control of rotavirus infection. Nat Immunol 16:698–707
Article PubMed PubMed Central Google Scholar
Holly MK, Diaz K, Smith JG (2017) Defensins in viral infection and Pathogenesis. Annu Rev Virol 4:369–391
Hong JK, Y,Schwendeman SP (2020) Characterization of Octreotide-PLGA binding by Isothermal Titration Calorimetry. Biomacromolecules 21:4087–4093
Hoy SM (2023) Motixafortide: first approval. Drugs 83:1635–1643
Hu H, Guo N, Chen S, Guo X, He Q (2019) Antiviral activity of Piscidin 1 against pseudorabies virus both in vitro and in vivo. Virol J, 16
Hu M, Wang F, Li N, Xing G, Sun X, Zhang Y, Cao S, Cui N, Zhang G (2021) An antigen display system of GEM nanoparticles based on affinity peptide ligands. Int J Biol Macromol 193:574–584
Joo SH (2012) Cyclic peptides as therapeutic agents and biochemical tools. Biomol Ther (Seoul) 20:19–26
Klotman ME, Chang TL (2006) Defensins in innate antiviral immunity. Nat Rev Immunol 6:447–456
König E, Bininda-Emonds OR, Shaw C (2015) The diversity and evolution of anuran skin peptides. Peptides 63:96–117
Kuba K, Imai Y, Ohto-Nakanishi T, Penninger JM (2010) Trilogy of ACE2: a peptidase in the renin-angiotensin system, a SARS receptor, and a partner for amino acid transporters. Pharmacol Ther 128:119–128
留言 (0)